Colorectal cancer (CRC) is the fourth most commonly diagnosed cancer and the third leading cause of cancer-related deaths worldwide. A substantial body of literature supports the crucial role of vitamin D (VD) in the etiology, progression, prognosis, and treatment of cancer. Recent clinical studies have found an inverse correlation between CRC incidence and serum VD levels. However, the low water solubility of VD and its anticarcinogenic activity at supraphysiological plasma levels, which causes hypercalcemia, required carrier systems. Carbon-based nanomaterials are excellent eco-friendly candidates, with exceptional chemical resistance, efficient mechanical properties, and negligible weight. Furthermore, composite aerogels manufactured from these nanomaterials have gained interest due to their extensive surface areas and porous structures, which make them suitable for delivering drugs. Our research aimed to study the development of composite aerogels loaded with VD by utilizing carbon nanofibers (CNFs) in an aerogel matrix provided to colon cancer cells. For this purpose, Aero1 as a drug delivery system was first prepared and characterized using XRD, FTIR, and SEM methods. Biochemical methods were employed to evaluate the antiproliferative, apoptotic, and anti-migratory effects on colon cancer cells. FTIR and XRD measurements confirmed the production of aerogels. SEM analysis revealed that aerogels have a non-uniform surface. The findings showed that aerogels can effectively deliver VD to the colon cancer cells, while also inhibiting cancer cell proliferation and migration. This research suggests that the Aero1 drug delivery system could be a valuable tool in the fight against colon cancer and other health issues.
Some novel triazole-bearing acetamide derivatives 9-26 were synthesized starting from carvacrol. All synthesized compounds were characterized by FTIR, 1H-NMR, 13C-NMR, HMBC and MS data. In vitro cytotoxic activities of all synthesized molecules against five cancer lines (human breast cancer MCF-7, human lung cancer A549, human prostate cancer PC-3, human chronic myelogenous leukemia K562, human neuroblastoma SH-SY5Y cell lines) were evaluated by MTT assay. Compounds were also tested on mouse embryonic fibroblast cells (NIH/3T3) to determine selectivity. Eighteen target compounds 9-26 were screened for their mPGES-1 and COX-1/2 inhibitory activities. Of these compounds, 26 (KUC16D425) showed the highest mPGES-1 inhibition at 10 µM. This compound have also been observed to induce apoptosis and inhibit cell migration in MCF-7 cells. In silico molecular docking calculations were performed to understand the binding interactions of compounds with target proteins. ADMET predictions were also done to evaluate drug-like properties of the novel compounds.
25 July 2024 in The European Chemistry and Biotechnology Journal
Cancer, the second-leading cause of death worldwide after cardiovascular diseases, is a deadly disease caused by numerous mutations that affect cell growth and differentiation. While there is no definitive cure for cancer yet, new target molecules are being identified with the help of developing technology, and appropriate treatment protocols are being developed. Since both normal and malignant cells are exposed to cytotoxic effects in traditional treatment methods, the development of less-side-effect and targeted treatment methods has become important. With the development of nanotechnology, the development of various nanodrug delivery systems (DDSs) has been targeted. In our study, we investigated the antiproliferative and antimicrobial activities of rutin-modified carbon nanofiber (ACNFr)-based aerogels loaded with krill oil (KO) (ACNFr-KO). Our results showed that ACNFr-KO aerogels were observed to have a significant anti-proliferative effect on the human breast cancer cell line MCF-7. In addition to this, ACNFr-KO aerogels were found to have antimicrobial activity against the gram-positive bacterium E. faecalis ATCC 29212. The results of our study suggest that rutin-modified CNF-based aerogels loaded with KO, which act as a DDS, have the potential to enhance targeted drug delivery and improve therapeutic outcomes in biomedical applications.
In this study, the synthesis and characterization of 2-(2-fluorobiphenyl-4-yl)-N´-[(substituted methylene]propanehydrazides (3a-s) and 2-(2-fluoro-[1,1'-biphenyl]-4-yl)-N-(5-methyl-2-(substituted aryl)-4-oxothiazolidin-3-yl)propanamides (4a-s) are described and also the antiproliferative effect of the compounds on HT-29, HeLa, A549 and MCF-7 cancer cell lines is investigated. Additionally, mouse embryonic fibroblast cells NIH3T3 were also evaluated to determine the selectivity. The results showed that the identified compounds did not cause any toxicity against NIH3T3 cell line. Moreover, N-(2-(3,5-Bis(trifluoromethyl)phenyl)-5-methyl-4-oxothiazolidin-3-yl)-2-(2-fluoro-[1,1'-biphenyl]-4-yl)propanamide (4h) had the most growth inhibitory effect (55.97% inhibition) on HT-29 colorectal adenocarcinoma cell line. The results obtained from the study show that the compound 4h, which has no cytotoxic effect on normal cells, may be an alternative in the treatment of colon cancer.
Introduction: Serenoa repens (W. Bartram) Small (Saw Palmetto), commonly referred to as the small palm, has been used in both traditional and modern medicine for centuries. Known for its diuretic, endocrinological, anabolic, and anti-inflammatory properties, Saw Palmetto is mostly used to treat benign prostatic hyperplasia (BPH). Known for its diuretic, endocrinological, anabolic, and anti-inflammatory properties, Saw Palmetto is mostly used to treat BPH. There has been a recent surge in interest in these products because herbal products are believed to be safer and have fewer side effects. Pharmacies stock many Saw Palmetto products authorized by the USA Department of Agriculture. People have begun to purchase these herbal products online as technology has advanced, especially during the COVID-19 pandemic, due to faster and easier access and cheaper costs. Many counterfeit products originate from popular e-commerce websites that sell goods that lack the necessary safety inspections. A literature review found that these products have adverse outcomes, including significant outcomes that can lead to death, which poses major public health concerns. The aim of this study was to compare the antiproliferative and genotoxic effects of Serenoa repens (W. Bartram) Small extracts obtained from two separate commercial sources, purchased over the internet and from a pharmacy, on human prostate cancer cell line (PC-3). Methods: The antiproliferative effect of Saw Palmetto extracts at different doses (10-200 µg/ml) was evaluated with the MTT test and the genotoxic effect was determined by the comet assay. Results: According to MTT results, the extract purchased from the pharmacy did not cause high inhibition in PC-3 cells at the entire dose range, while higher inhibition values were recorded in the extract obtained from the internet. On the other hand, when the genotoxic activities of both extracts were examined, it was determined that the DNA damage caused by the product purchased from the pharmacy in PC-3 cells was lower than the product purchased from the internet. Conclusions: This research highlights the health risks of herbal products purchased online and the need to source dietary supplements from trusted suppliers. It is crucial to change this view and increase public awareness to ensure safer use of herbal products.
24 August 2023 in Fabad Journal of Pharmaceutical Sciences
Some new triazole containing acetamide derivatives 9-20 using paracetamol as starting material were synthesized and their structure were characterized by FTIR, 1H-NMR, 13C-NMR and MS data. In vitro cytotoxic activities of all synthesized molecules against five cancer cell lines (human lung cancer A549, human chronic myelogenous leukemia K562, human breast cancer MCF-7, human prostate cancer PC-3, human neuroblastoma SH-SY5Y cell lines) were examined and were also tested their cytotoxic effect on mouse embryonic fibroblast cells (NIH/3T3) to define selectivity. MTT assay were used these in vitro activity studies. Additionally, twelve target compounds 9-20 were screened for their mPGES-1 and COX-1/2 inhibitory activities. While none of the synthesized compounds showed a significant inhibition against both cancer cells and mPGES-1 as well as COX-1/2, it was determined that they were not cytotoxic against healthy cells, too. Finally, ADMET data were presented by predicting the drug-like properties of newly synthesized compounds using computational methods.